Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Baxter
Express Scripts
Johnson and Johnson
Colorcon

Last Updated: December 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Tipifarnib

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Tipifarnib?

Tipifarnib is an investigational drug.

There have been 79 clinical trials for Tipifarnib. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2004.

The most common disease conditions in clinical trials are Leukemia, Leukemia, Myeloid, and Leukemia, Myeloid, Acute. The leading clinical trial sponsors are National Cancer Institute (NCI), Johnson & Johnson Pharmaceutical Research & Development, L.L.C., and Kura Oncology, Inc.

Recent Clinical Trials for Tipifarnib
TitleSponsorPhase
Safety and Efficacy of Tipifarnib in Head and Neck Cancer With HRAS Mutations and Impact of HRAS on Response to TherapyKura Oncology, Inc.Phase 2
Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionSSpanish Lung Cancer GroupPhase 2
Tipifarnib in Subjects With Chronic Myelomonocytic LeukemiaKura Oncology, Inc.Phase 2

See all Tipifarnib clinical trials

Clinical Trial Summary for Tipifarnib

Top disease conditions for Tipifarnib
Top clinical trial sponsors for Tipifarnib

See all Tipifarnib clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
McKesson
Harvard Business School
Johnson and Johnson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.